Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Alzheimer's Disease

Free Subscription 11.03.2019 3 Alzheimers Dement 2 Am J Epidemiol 1 Ann Neurol 2 BMC Geriatr 2 BMJ 5 Curr Alzheimer Res 1 Lancet Neurol 1 Nat Med 1 Nat Rev Neurol 2 Neurology 5 Neurosci Lett 3 Neuroscience 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Alzheimers Dement

1. JELLINGER KA
   Parkinsonism in MCI or mild Alzheimer's disease.
   Alzheimers Dement. 2019 Feb 28. pii: S1552-5260(19)30002.
   PubMed     Text format    
   
   
2. SCHINDLER SE, Li Y, Todd KW, Herries EM, et al
   Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease.
   Alzheimers Dement. 2019 Mar 4. pii: S1552-5260(19)30013.
   PubMed     Text format     Abstract available
   
   
3. GUTIERREZ J, Guzman V, Khasiyev F, Manly J, et al
   Brain arterial dilatation and the risk of Alzheimer's disease.
   Alzheimers Dement. 2019 Feb 28. pii: S1552-5260(19)30012.
   PubMed     Text format     Abstract available
   
   

   
   Am J Epidemiol

4. MAYEDA ER
   Examining sex/gender differences in risk of Alzheimer's disease and related dementias: Challenges and future directions.
   Am J Epidemiol. 2019 Mar 2. pii: 5368301. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
5. BUCKLEY RF, Waller M, Masters CL, Dobson A, et al
   To What Extent Does Age at Death Account for Sex Differences in Alzheimer's Disease Mortality Rates?
   Am J Epidemiol. 2019 Mar 2. pii: 5368304. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Ann Neurol

6. WADHWANI AR, Affaneh A, Van Gulden S, Kessler JA, et al
   Neuronal Apolipoprotein E4 increases cell death and p-tau release in Alzheimer's disease.
   Ann Neurol. 2019 Mar 6. doi: 10.1002/ana.25455.
   PubMed     Text format     Abstract available
   
   

   
   BMC Geriatr

7. WANG Y, Xiao LD, Luo Y, Xiao SY, et al
   Community health professionals' dementia knowledge, attitudes and care approach: a cross-sectional survey in Changsha, China.
   BMC Geriatr. 2018;18:122.
   PubMed     Text format     Abstract available
   
   
8. PARRA-ANGUITA L, Sanchez-Garcia I, Del Pino-Casado R, Pancorbo-Hidalgo PL, et al
   Measuring knowledge of Alzheimer's: development and psychometric testing of the UJA Alzheimer's Care Scale.
   BMC Geriatr. 2019;19:63.
   PubMed     Text format     Abstract available
   
   

   
   BMJ

9. SAVOLAINEN-PELTONEN H, Rahkola-Soisalo P, Hoti F, Vattulainen P, et al
   Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study.
   BMJ. 2019;364:l665.
   PubMed     Text format     Abstract available
   
   
10. IACOBUCCI G
    Long term hormone therapy may increase Alzheimer's risk, study finds.
    BMJ. 2019;364:l1050.
    PubMed     Text format    
    
    

    
    Curr Alzheimer Res

11. ZENG K, Li M, Hu J, Mahaman YAR, et al
    Ginkgo biloba Extract EGb761 Attenuates Hyperhomocysteinemia-induced AD Like Tau Hyperphosphorylation and Cognitive Impairment in Rats.
    Curr Alzheimer Res. 2018;15:89-99.
    PubMed     Text format     Abstract available
    
    
12. TEIPEL S, Kilimann I, Thyrian JR, Kloppel S, et al
    Potential Role of Neuroimaging Markers for Early Diagnosis of Dementia in Primary Care.
    Curr Alzheimer Res. 2018;15:18-27.
    PubMed     Text format     Abstract available
    
    
13. RUGGIERO G, Iachini T
    Editorial: Spatial Cognition in Normal Aging, MCI and AD.
    Curr Alzheimer Res. 2018;15:202-204.
    PubMed     Text format    
    
    
14. BAZZARI FH, Abdallah DM, El-Abhar HS
    Pharmacological Interventions to Attenuate Alzheimer's Disease Progression: The Story So Far.
    Curr Alzheimer Res. 2019 Feb 28. pii: CAR-EPUB-96968.
    PubMed     Text format     Abstract available
    
    
15. DEL PERCIO C, Drinkenburg W, Lopez S, Limatola C, et al
    Ongoing Electroencephalographic Activity Associated with Cortical Arousal in Transgenic PDAPP Mice (hAPP V717F).
    Curr Alzheimer Res. 2018;15:259-272.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Neurol

16. ZIMMERMANN JF, Butler CR
    Accelerated long-term forgetting in asymptomatic APOE epsilon4 carriers.
    Lancet Neurol. 2018;17:394-395.
    PubMed     Text format    
    
    

    
    Nat Med

17. STOWER H
    Linking Alzheimer's disease and frailty.
    Nat Med. 2019 Mar 6. pii: 10.1038/s41591-019-0399.
    PubMed     Text format    
    
    

    
    Nat Rev Neurol

18. BERTRAM L, Tanzi RE
    Alzheimer disease risk genes: 29 and counting.
    Nat Rev Neurol. 2019 Mar 4. pii: 10.1038/s41582-019-0158.
    PubMed     Text format    
    
    

    
    Neurology

19. VOS SJB, Duara R
    The prognostic value of ATN Alzheimer biomarker profiles in cognitively normal individuals.
    Neurology. 2019 Mar 6. pii: WNL.0000000000007223.
    PubMed     Text format    
    
    
20. MESULAM MM, Lalehzari N, Rahmani F, Ohm D, et al
    Cortical cholinergic denervation in primary progressive aphasia with Alzheimer pathology.
    Neurology. 2019 Mar 6. pii: WNL.0000000000007247.
    PubMed     Text format     Abstract available
    
    

    
    Neurosci Lett

21. LIN S, Wei L, Ping Y, Xia L, et al
    Upregulated BMP6 pathway involved in the pathogenesis of Abeta toxicity in vivo.
    Neurosci Lett. 2018;664:152-159.
    PubMed     Text format     Abstract available
    
    
22. WANG M, Jing T, Wang X, Yao D, et al
    Beta-secretase/BACE1 promotes APP endocytosis and processing in the endosomes and on cell membrane.
    Neurosci Lett. 2018;685:63-67.
    PubMed     Text format     Abstract available
    
    
23. WU X, Kosaraju J, Tam KY
    Anti-neuroinflammatory effects of SLOH in Abeta-induced BV-2 microglial cells and 3xTg-AD mice involve the inhibition of GSK-3beta.
    Neurosci Lett. 2018;687:207-215.
    PubMed     Text format     Abstract available
    
    
24. ZHANG N, Parr CJC, Birch AM, Goldfinger MH, et al
    The amyloid precursor protein binds to beta-catenin and modulates its cellular distribution.
    Neurosci Lett. 2018;685:190-195.
    PubMed     Text format     Abstract available
    
    
25. BECKER M, Moore A, Naughton M, Boland B, et al
    Neprilysin degrades murine Amyloid-beta (Abeta) more efficiently than human Abeta: Further implication for species-specific amyloid accumulation.
    Neurosci Lett. 2018;686:74-79.
    PubMed     Text format     Abstract available
    
    

    
    Neuroscience

26. BUCCARELLO L, Musi CA, Turati A, Borsello T, et al
    The Stress c-Jun N-terminal Kinase Signaling Pathway Activation Correlates with Synaptic Pathology and Presents A Sex Bias in P301L Mouse Model of Tauopathy.
    Neuroscience. 2018;393:196-205.
    PubMed     Text format     Abstract available
    
    
27. SEPULVEDA C, Hernandez B, Burgos CF, Fuentes E, et al
    The cAMP/PKA Pathway Inhibits Beta-amyloid Peptide Release from Human Platelets.
    Neuroscience. 2019;397:159-171.
    PubMed     Text format     Abstract available
    
    
28. WANG S, Huang L, Zhang Y, Peng Y, et al
    Protective Effects of L-3-n-Butylphthalide Against H2O2-Induced Injury in Neural Stem Cells by Activation of PI3K/Akt and Mash1 Pathway.
    Neuroscience. 2018;393:164-174.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

29. MARTI-JUAN G, Sanroma G, Piella G
    Revealing heterogeneity of brain imaging phenotypes in Alzheimer's disease based on unsupervised clustering of blood marker profiles.
    PLoS One. 2019;14:e0211121.
    PubMed     Text format     Abstract available
    
    
30. OH ES, Blennow K, Bigelow GE, Inouye SK, et al
    Abnormal CSF amyloid-beta42 and tau levels in hip fracture patients without dementia.
    PLoS One. 2018;13:e0204695.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: